-transparent.png){kind=logo}
Samples from malignant epithelial ovarian tumors were examined for expression of Ki-67, DNA ploidy and S-phase fraction (SPF). In addition, normal ovary, benign and borderline tumors were immunostained with Ki-67 to examine its role in ovarian carcinogenesis and to estimate the prognostic significance. For both Ki-67, ploidy and SFP a significant correlation to survival in malignancy was observed. Furthermore, SPF above 10% showed significant correlation to decreased survival in both stage subgroups I-II and III-IV, while for aneuploidy a decrease in survival could be detected only in localized disease. Ki-67 expression was present in tumor cells in the main part of borderline and malignant tumors and even in 2 benign counterparts, which might indicate an active state in these commonly believed dormant neoplasms. In the malignant group the Ki-67 correlation to survival seemed to be independent of staining intensity, although the observed decay in survival seemed to be faster in the strongly stained group.
R Henriksen, and
P Strang, and
T Backstrom, and
E Wilander, and
B Tribukait, and
K Oberg
April 1987,
Pathology, research and practice,
R Henriksen, and
P Strang, and
T Backstrom, and
E Wilander, and
B Tribukait, and
K Oberg
December 2004,
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi,
R Henriksen, and
P Strang, and
T Backstrom, and
E Wilander, and
B Tribukait, and
K Oberg
September 1993,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R Henriksen, and
P Strang, and
T Backstrom, and
E Wilander, and
B Tribukait, and
K Oberg
January 2001,
Pathology, research and practice,
R Henriksen, and
P Strang, and
T Backstrom, and
E Wilander, and
B Tribukait, and
K Oberg
February 2017,
Journal of clinical and diagnostic research : JCDR,
R Henriksen, and
P Strang, and
T Backstrom, and
E Wilander, and
B Tribukait, and
K Oberg
January 2001,
Advances in clinical pathology : the official journal of Adriatic Society of Pathology,
R Henriksen, and
P Strang, and
T Backstrom, and
E Wilander, and
B Tribukait, and
K Oberg
September 1993,
Gynecologic oncology,
R Henriksen, and
P Strang, and
T Backstrom, and
E Wilander, and
B Tribukait, and
K Oberg
January 2002,
The breast journal,
R Henriksen, and
P Strang, and
T Backstrom, and
E Wilander, and
B Tribukait, and
K Oberg
June 1989,
Gynecologic oncology,
R Henriksen, and
P Strang, and
T Backstrom, and
E Wilander, and
B Tribukait, and
K Oberg
December 1998,
Clinical otolaryngology and allied sciences,
